Stock listing

NASDAQ:TCRT Alaunos Therapeutics, Inc. Stock

Home listing (NASDAQ) of Alaunos Therapeutics, Inc.

Follow Alaunos Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:TCRT

$1.75 USD -0.20 (-10.3%)

Close on Nov 2, 2026

Past year -35.4% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$1.75 – $1.96 USDNov 2, 2026
Volume
162,251 sharesNov 2, 2026
Market cap
$6.02M USDAt the close on Nov 2, 2026 · price × 3.44M shares outstanding
52-week range
$0.72 – $4.50 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$19.59M USDMedian day 38,800 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Alaunos Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TCRT · Home$1.75 USD-0.20 (-10.3%)162,251$1.94$1.96$1.75$1.95Close on Nov 2, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:TCRT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.75-0.20-10.3%$1.94$1.96$1.75162,251
$1.95+0.06+3.2%$1.84$2.04$1.675768,606
$1.89-0.24-11.3%$2.00$2.09$1.87452,044
$2.13+0.07+3.4%$2.14$2.19$2.00646,044
$2.06-0.07-3.3%$1.883$2.08$1.88377,153
$2.13-0.15-6.6%$2.331$2.359$2.011532,016
$2.28-0.76-25.0%$2.83$2.86$2.181,333,700
$3.04-0.04-1.3%$3.19$3.26$2.901,483,400
$3.08+0.11+3.7%$3.13$3.33$2.812,603,800
$2.97-0.16-5.1%$2.77$3.26$2.763,715,500
$3.13+0.50+19.0%$2.98$3.49$2.8241,243,400
$2.63+0.45+20.6%$2.81$2.99$2.3132,224,600
$2.18+0.11+5.3%$2.03$2.39$1.8016,673,300
$2.07-0.96-31.7%$3.68$4.40$1.8868,561,300
$3.03+1.98+188.6%$1.73$4.32$1.51256,847,300
$1.05+0.26+32.9%$0.78$1.05$0.773,422,600
$0.79+0.01+1.3%$0.80$0.80$0.7849,700
$0.78-0.06-7.1%$0.84$0.85$0.7889,900
$0.84+0.10+13.5%$0.74$0.89$0.72309,300
$0.74-0.06-7.5%$0.79$0.82$0.72121,100
$0.80-0.02-2.4%$0.81$0.82$0.7848,100
$0.82-0.10-10.9%$0.90$0.94$0.8286,500
$0.92+0.03+3.4%$0.91$0.95$0.8993,800
$0.89-0.07-7.3%$0.95$1.00$0.85125,800
$0.96-0.06-5.9%$1.03$1.05$0.9636,500
$1.02-0.07-6.4%$1.06$1.10$0.97149,200
$1.09-0.04-3.5%$1.13$1.13$1.0881,300
$1.13-0.02-1.7%$1.14$1.16$1.10196,900
$1.15-0.12-9.4%$1.21$1.27$1.10201,700
$1.27+0.01+0.8%$1.19$1.34$1.17360,900
$1.26+0.06+5.0%$1.26$1.35$1.22667,600
$1.20-0.40-25.0%$1.57$1.60$1.0232,765,300
$1.60+0.32+25.0%$1.35$1.65$1.2915,138,800
$1.28-0.13-9.2%$1.41$1.42$1.2837,000
$1.41-0.08-5.4%$1.47$1.49$1.4115,800
$1.49-0.02-1.3%$1.50$1.54$1.499,600
$1.51-0.05-3.2%$1.52$1.53$1.5018,200
$1.560.000.0%$1.53$1.56$1.525,300
$1.56-0.01-0.6%$1.60$1.60$1.5517,200
$1.57-0.06-3.7%$1.63$1.63$1.5613,900
$1.63-0.02-1.2%$1.68$1.68$1.623,400
$1.65-0.02-1.2%$1.67$1.68$1.652,900
$1.67+0.01+0.6%$1.59$1.70$1.598,500
$1.66-0.04-2.4%$1.70$1.70$1.616,400
$1.70+0.09+5.6%$1.57$1.73$1.5712,900
$1.61-0.05-3.0%$1.66$1.71$1.5535,600
$1.66-0.12-6.7%$1.79$1.79$1.6220,800
$1.78-0.01-0.6%$1.79$1.79$1.694,200
$1.79+0.07+4.1%$1.74$1.80$1.6919,300
$1.72-0.04-2.3%$1.77$1.78$1.714,300
$1.76-0.04-2.2%$1.82$1.84$1.7315,100
$1.80-0.08-4.3%$1.87$1.97$1.7538,800
$1.880.000.0%$1.94$1.94$1.883,400
$1.88-0.03-1.6%$1.90$1.90$1.837,900
$1.91-0.02-1.0%$2.05$2.05$1.8517,700
$1.93-0.06-3.0%$1.98$1.98$1.9311,600
$1.99-0.01-0.5%$1.96$2.02$1.967,800
$2.00+0.03+1.5%$1.91$2.00$1.917,200
$1.97-0.01-0.5%$1.92$1.99$1.924,800
$1.98-0.01-0.5%$1.92$1.99$1.9210,200
$1.990.000.0%$1.97$2.00$1.956,100
$1.99-0.03-1.5%$2.00$2.00$1.995,000
$2.02+0.12+6.3%$1.89$2.02$1.8911,800
$1.90-0.01-0.5%$1.88$1.96$1.8511,000
$1.91+0.03+1.6%$1.86$1.93$1.864,900
Ticker
NASDAQ:TCRT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Alaunos Therapeutics (NASDAQ:TCRT) Q1 2023 Earnings Call

    Wed, May 10, 2023 · 9:00 AM ET

    Watch Transcript
  • Alaunos Therapeutics (NASDAQ:TCRT) Q4 2022 Earnings Call

    Tue, Mar 07, 2023 · 8:30 AM ET

    Watch Transcript
  • Alaunos Therapeutics (NASDAQ:TCRT) Q3 2022 Earnings Call

    Mon, Nov 14, 2022 · 8:30 AM ET

    Watch Transcript

Latest news

All Alaunos Therapeutics, Inc. news

Financings

  • Private placement of series C non-voting convertible preferred stock

    Oct 13, 2026

    Closed: US$350M raised · Jefferies +4

    Dealers: Jefferies, TD Cowen, Stifel, UBS Investment Bank, Wedbush & Co., LLC

    Buyers: Fairmount (led the private placement); Venrock Healthcare Capital Partners; T. Rowe Price Investment Management, Inc. (certain accounts advised by); Wellington Management; Janus Henderson Investors; Access Biotechnology; BB Biotech; Perceptive Advisors; Sirenia Capital Management LP; ADAR1 Capital Management

    Use of proceeds: Fund operations into 2029, including proof-of-concept data for VLR199 and VLR360 and initial regulatory filings for VLR247 and VLR258

    Closed Oct 13, 2026

  • Registered direct offering of common stock and pre-funded warrants

    Sep 18, 2026

    Announced: about US$1.12M · US$1.46 a share · Dawson James Securities, Inc.

    Dealers: Dawson James Securities, Inc. (lead)

    Use of proceeds: General working capital and corporate purposes

    Announced Sep 18, 2026

Read by 6ix AI from the company's releases

Decks

Alaunos Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
7 in the last 12 months · 33 in all · newest Oct 13, 2026 · oldest 2022
Calls
10 calls with a replay · 10 with a transcript · latest May 10, 2023
Decks
50 decks · latest Oct 13, 2026

Where Alaunos Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TCRT · Home listing · This pageNASDAQUnited StatesUSD
BOATS:TCRTBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Alaunos Therapeutics, Inc.